Literature DB >> 23891366

Brain stimulation in the treatment of late-life severe mental illness other than unipolar nonpsychotic depression.

Angela Y Liu1, Tarek K Rajji2, Daniel M Blumberger3, Zafiris J Daskalakis4, Benoit H Mulsant5.   

Abstract

Late-life mental illness is a growing concern. Current medications have limited efficacy and are associated with safety concerns. A variety of brain stimulation approaches offers alternative treatments. We performed a systematic literature search on the efficacy and safety of brain stimulation in late-life mental illnesses, excluding unipolar nonpsychotic depression. Studies on deep brain stimulation, electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS), and vagal nerve stimulation that enrolled exclusively older adults (≥65 years) or analyzed older adults as a separate group were included. The search identified 1,181 publications, of which 43 met the above inclusion criteria: 24 were related to the treatment of non-unipolar depression (ECT: 21; rTMS: 2; ECT and rTMS: 1), 14 related to dementia (ECT: 7[2 of these studies were also related to depression]; vagal nerve stimulation: 2; rTMS: 4; deep brain stimulation: 1), and 7 to schizophrenia (ECT: 7). These studies reported a high degree of variability in efficacy and safety with promising results in general, particularly in the treatment of dementia and schizophrenia. Most publications were limited by small sample sizes, lack of control conditions, and lack of randomization. Large studies with a randomized controlled design or other designs such as crossover or off-on-off-on are needed. In contrast to the empiric and nonspecific use of ECT, future studies using modalities other than ECT could focus on novel biologically based interventions that target specific circuitry. These interventions could also be combined with other non-brain stimulation treatments for possible synergistic effects.
Copyright © 2014 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain stimulation; ECT; elderly; mental illness; transcranial magnetic stimulation

Mesh:

Year:  2013        PMID: 23891366      PMCID: PMC3900599          DOI: 10.1016/j.jagp.2013.02.017

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  64 in total

1.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

2.  Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death.

Authors:  Elisabetta Patorno; Rhonda L Bohn; Peter M Wahl; Jerry Avorn; Amanda R Patrick; Jun Liu; Sebastian Schneeweiss
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

3.  Improved language performance in Alzheimer disease following brain stimulation.

Authors:  Maria Cotelli; Marco Calabria; Rosa Manenti; Sandra Rosini; Orazio Zanetti; Stefano F Cappa; Carlo Miniussi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-23       Impact factor: 10.154

4.  Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone.

Authors:  Kazumasa Suzuki; Shuichi Awata; Takehisa Takano; Yukio Ebina; Tsuyoshi Shindo; Nobuhiko Harada; Hiroo Matsuoka
Journal:  Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.188

5.  Antiepileptic drugs and risk of suicide: a nationwide study.

Authors:  Jonas Bjerring Olesen; Peter Riis Hansen; Jesper Erdal; Steen Zabell Abildstrøm; Peter Weeke; Emil Loldrup Fosbøl; Henrik Enghusen Poulsen; Gunnar H Gislason
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-05       Impact factor: 2.890

6.  Treatment of agitation and aggression in four demented patients using ECT.

Authors:  J E Grant; S N Mohan
Journal:  J ECT       Date:  2001-09       Impact factor: 3.635

Review 7.  Older patients with schizophrenia: challenges in the coming decades.

Authors:  B W Palmer; S C Heaton; D V Jeste
Journal:  Psychiatr Serv       Date:  1999-09       Impact factor: 3.084

Review 8.  Electroconvulsive therapy in patients with long bone fractures.

Authors:  D Dighe-Deo; A Shah
Journal:  J ECT       Date:  1998-06       Impact factor: 3.635

9.  Treatment of vascular depression using repetitive transcranial magnetic stimulation.

Authors:  Ricardo E Jorge; David J Moser; Laura Acion; Robert G Robinson
Journal:  Arch Gen Psychiatry       Date:  2008-03

10.  Antipsychotic drug use and mortality in older adults with dementia.

Authors:  Sudeep S Gill; Susan E Bronskill; Sharon-Lise T Normand; Geoffrey M Anderson; Kathy Sykora; Kelvin Lam; Chaim M Bell; Philip E Lee; Hadas D Fischer; Nathan Herrmann; Jerry H Gurwitz; Paula A Rochon
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

View more
  7 in total

1.  Response to Letter to the Editor regarding "Transcranial magnetic stimulation for treatment-resistant depression: Naturalistic outcomes for younger versus older patients".

Authors:  Christine A Conelea; Noah S Philip; Augustin G Yip; Jennifer L Barnes; Matthew J Niedzwiecki; Benjamin D Greenberg; Audrey R Tyrka; Linda L Carpenter
Journal:  J Affect Disord       Date:  2017-08-12       Impact factor: 4.839

Review 2.  Transcranial Magnetic Stimulation (TMS) in the Elderly.

Authors:  Ilva G Iriarte; Mark S George
Journal:  Curr Psychiatry Rep       Date:  2018-02-10       Impact factor: 5.285

3.  [Electroconvulsive therapy to treat therapy-resistant vocalization in dementia].

Authors:  M Guhra; B Rohden; S Spannhorst; M Driessen; S H Kreisel
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

4.  Cognition in Late Life Depression: Treatment Considerations.

Authors:  Aaron M Koenig; Meryl A Butters
Journal:  Curr Treat Options Psychiatry       Date:  2014-03-01

5.  Comparison of hemodynamic changes and serum potassium levels in the use of succinylcholine and cisatracurium in electroconvulsive therapy.

Authors:  Behzad Nazemroaya; Atefeh Ghosouri; Azim Honarmand; Seyed Taghi Hashemi
Journal:  J Res Med Sci       Date:  2021-11-29       Impact factor: 1.852

6.  Multimodal MRI of the hippocampus in Parkinson's disease with visual hallucinations.

Authors:  Nailin Yao; Charlton Cheung; Shirley Pang; Richard Shek-kwan Chang; Kui Kai Lau; John Suckling; Kevin Yu; Henry Ka-Fung Mak; Siew Eng Chua; Shu-Leong Ho; Grainne M McAlonan
Journal:  Brain Struct Funct       Date:  2014-10-07       Impact factor: 3.270

Review 7.  Adverse events of repetitive transcranial magnetic stimulation in older adults with depression, a systematic review of the literature.

Authors:  Geke M Overvliet; Rebecca A C Jansen; Anton J L M van Balkom; Dilene C van Campen; Mardien L Oudega; Ysbrand D van der Werf; Eric van Exel; Odile A van den Heuvel; Annemiek Dols
Journal:  Int J Geriatr Psychiatry       Date:  2020-11-06       Impact factor: 3.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.